CAS: 918633-87-1 - Evofosfamide
Formula:C9H16Br2N5O4P
InChI:InChI=1S/C9H16Br2N5O4P/c1-15-8(6-12-9(15)16(17)18)7-20-21(19,13-4-2-10)14-5-3-11/h6H,2-5,7H2,1H3,(H2,13,14,19)
InChI key:InChIKey=UGJWRPJDTDGERK-UHFFFAOYSA-N
SMILES:O=N(=O)C1=NC=C(N1C)COP(=O)(NCCBr)NCCBr
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Evofosfamide REF: TM-T3615CAS: 918633-87-1 | 99.3% - 99.75% | 52,00 €~1.318,00 € | Mar 10 Dic 24 |
 | TH-302 REF: TR-T338200CAS: 918633-87-1 | - - - | 397,00 €~1.508,00 € | Lun 13 Gen 25 |
 | (1-Methyl-2-nitro-1H-imidazol-5-yl)methyl N,N'-bis(2-bromoethyl)phosphorodiamidate REF: 3D-TLB63387CAS: 918633-87-1 | Min. 95% | Prezzo su richiesta | Mar 14 Gen 25 |
Evofosfamide
CAS:918633-87-1
Evofosfamide (TH-302) is a hypoxia-activated prodrug that releases Br-IPM in tumors to cause DNA damage …
Formula:
C9H16Br2N5O4P
Purezza:
99.3% - 99.75%
Colore e forma:
Solid
Peso molecolare:
449.04
Ref: TM-T3615
| 1mg | 52,00 € | ||
| 5mg | 109,00 € | ||
| 10mg | 150,00 € | ||
| 25mg | 257,00 € | ||
| 50mg | 412,00 € | ||
| 100mg | 634,00 € | ||
| 500mg | 1.318,00 € | ||
| 1mL*10mM (DMSO) | 109,00 € |
Consegna stimata in Stati Uniti, il Martedì 10 Dicembre 2024
TH-302
Prodotto ControllatoCAS:918633-87-1
Applications TH-302 is a 2-nitroimidazole triggered hypoxia-activated prodrug (HAP) of bromo-isophosphoramide mustard. Studies have shown …
Formula:
C9H16Br2N5O4P
Colore e forma:
Neat
Peso molecolare:
449.04
Ref: TR-T338200
| 5mg | 397,00 € | ||
| 10mg | 549,00 € | ||
| 50mg | 1.508,00 € |
Consegna stimata in Stati Uniti, il Lunedì 13 Gennaio 2025
(1-Methyl-2-nitro-1H-imidazol-5-yl)methyl N,N'-bis(2-bromoethyl)phosphorodiamidate
CAS:918633-87-1
Th-302 is a phosphorodiamidate prodrug that is converted to methyl N,N'-bis(2-bromoethyl)phosphorodiamidate (th-302) in the body. …
Formula:
C9H16Br2N5O4P
Purezza:
Min. 95%
Peso molecolare:
449.04 g/mol
Ref: 3D-TLB63387
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 14 Gennaio 2025
